Physician

David B Sokol, M.D.

According to 2025 Medicare claims, David Sokol, M.D. (NPI: 1235163833) practices hematology/oncology in the Trenton-Princeton, NJ market, with the plurality of this provider's patient population coming from Mercer, NJ. This provider's primary affiliated billing organization is CLINICAL HEALTHCARE ASSOCIATES OF NEW JERSEY SPECIALTY PRACTICES PC (NPI: 1639986458; TIN: 331946468) and primary practice location at 08536-1915. Sokol is affiliated with the Penn Medicine Healthcare Partners, LLC (ACO ID: A5318), participating under the MSSP model.

Sokol's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 353 traditional Medicare patients, billed 45,514 HCPCS/CPT codes, and received $783,265 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 941 prescription claims across 161 beneficiaries totaling $4,424,897 in drug costs, led by Calquence (Acalabrutinib Maleate). DME data shows 22 claims. Open Payments data shows 5 records totaling $82. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $242,731 to $783,265. Similarly, Part D prescription costs have moved from a lower plateau to a higher plateau, from $806,803 to $4,424,897. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $3,498 to $649.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	306	8,014	$242,731
2016	392	38,783	$601,417
2017	349	18,622	$511,242
2018	370	21,017	$507,341
2019	370	33,160	$641,659
2020	375	43,342	$721,476
2021	359	36,449	$755,506
2022	365	18,179	$629,131
2023	346	40,067	$812,751
2024	353	45,514	$783,265

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	82	444	$806,803
2016	103	689	$1,158,263
2017	118	654	$1,410,467
2018	129	802	$2,329,351
2019	150	827	$2,441,968
2020	147	969	$2,471,875
2021	157	892	$2,296,457
2022	138	690	$1,757,447
2023	156	809	$2,109,533
2024	161	941	$4,424,897

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	80	$19,959
2016	N/R	72	$27,927
2017	N/R	158	$38,457
2018	N/R	44	$9,084
2019	N/R	36	$3,576
2020	N/R	122	$10,889
2021	N/R	160	$5,113
2022	N/R	109	$2,763
2023	N/R	134	$8,394
2024	N/R	22	$557

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	172	468	$105
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	90	109	$60
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	202	433	$14
36415	Insertion of needle into vein for collection of blood sample	125	360	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	113	478	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Calquence	Acalabrutinib Maleate	42	1,560	$707,748
Jakafi	Ruxolitinib Phosphate	32	960	$604,733
Pomalyst	Pomalidomide	23	644	$469,766
Tagrisso	Osimertinib Mesylate	24	720	$448,341
Revlimid	Lenalidomide	20	560	$358,573

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	11	$400
J9190	Injection, fluorouracil, 500 mg	N	N/R	11	$156

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$82	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for David B. Sokol, M.D.?

Tedicare shows public-source Medicare data for David B. Sokol, M.D. (NPI 1235163833), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David B. Sokol, M.D. have ACO affiliation data?

David B. Sokol, M.D. is shown with ACO affiliation data for Penn Medicine Healthcare Partners, LLC (MSSP, ACO ID A5318).

What billing organization is linked to David B. Sokol, M.D.?

David B. Sokol, M.D. is linked to CLINICAL HEALTHCARE ASSOCIATES OF NEW JERSEY SPECIALTY PRACTICES PC (billing NPI 1639986458) in the available physician profile data.

Does David B. Sokol, M.D. have Open Payments data?

David B. Sokol, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.